PDE10A and Huntington disease: Another study using the PED10A ligand, [11]C‐IMA107, showed bidirectional changes in PDE10A expression in premanifest HD gene carriers, with lower binding in the striatum and pallidum and increased binding in motor thalamic nuclei than in healthy volunteers.50